PAK-200

N/A

Report date: 2022/08/23 20:00:44

Base Information

Drug NamePAK-200
Drug Alias NamePAK-200S
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsReperfusion InjuryNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryJapan
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesNissan Chemical Industries Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Active IndicationsN/A
Inactive IndicationsReperfusion InjuryNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A